{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:01:34Z","timestamp":1790323294418,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570468"],"award-info":[{"award-number":["82570468"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05929-y","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:22:58Z","timestamp":1790320978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dexmedetomidine attenuates hypoxia\/reoxygenation-induced cardiomyocyte injury in association with ADRA2A\/ADRA2B and Notch1\/Hes1 modulation"],"prefix":"10.1007","author":[{"given":"Dinghao","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"5929_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2174\/0118744710312688240814100448","volume":"18","author":"A Davari","year":"2025","unstructured":"Davari A, Jalali-zefrei F, Gholami-chabok B, Tabaghi S, Farzipour S, Delpasand K et al (2025) Left ventricular wall motion as an additional valuable parameter in diabetic patients with normal myocardial perfusion imaging. Curr Radiopharm 18:141\u2013146. https:\/\/doi.org\/10.2174\/0118744710312688240814100448","journal-title":"Curr Radiopharm"},{"key":"5929_CR2","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.2147\/dddt.s428024","volume":"17","author":"H He","year":"2023","unstructured":"He H, Liu P, Li P (2023) Dexmedetomidine ameliorates cardiac ischemia\/reperfusion injury by enhancing autophagy through activation of the AMPK\/SIRT3 pathway. Drug des Devel Ther 17:3205\u20133218. https:\/\/doi.org\/10.2147\/dddt.s428024","journal-title":"Drug des Devel Ther"},{"key":"5929_CR3","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.xcrm.2024.101084","volume":"5","author":"G Heusch","year":"2024","unstructured":"Heusch G (2024) Myocardial ischemia\/reperfusion: Translational success stories. Cell Reports Medicine 5:101084. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101084","journal-title":"Cell Reports Medicine"},{"key":"5929_CR4","doi-asserted-by":"publisher","first-page":"2158526","DOI":"10.1080\/13510002.2022.2158526","volume":"28","author":"B Hu","year":"2023","unstructured":"Hu B, Tian T, Li X-T, Hao P-P, Liu W-C, Chen Y-G et al (2023) Dexmedetomidine postconditioning attenuates myocardial ischemia\/reperfusion injury by activating the Nrf2\/Sirt3\/SOD2 signaling pathway in the rats. Redox Rep 28:2158526. https:\/\/doi.org\/10.1080\/13510002.2022.2158526","journal-title":"Redox Rep"},{"key":"5929_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41419-022-04533-1","volume":"13","author":"J Lin","year":"2022","unstructured":"Lin J, Li Q, Jin T, Wang J, Gong Y, Lv Q et al (2022) Cardiomyocyte IL-1R2 protects heart from ischemia\/reperfusion injury by attenuating IL-17RA-mediated cardiomyocyte apoptosis. Cell Death Dis 13:90. https:\/\/doi.org\/10.1038\/s41419-022-04533-1","journal-title":"Cell Death Dis"},{"key":"5929_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s44254-024-00084-0","volume":"3","author":"J Lin","year":"2025","unstructured":"Lin J, Li X, Yang Y, Ge Z, Liu D, Yang C et al (2025) Protective effects of sevoflurane conditioning against myocardial ischemia-reperfusion injury: A review of evidence from animal and clinical studies. Anesthesiol Perioper Sci 3:4. https:\/\/doi.org\/10.1007\/s44254-024-00084-0","journal-title":"Anesthesiol Perioper Sci"},{"key":"5929_CR7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.2174\/0115701646320190241231083203","volume":"21","author":"W Liu","year":"2024","unstructured":"Liu W, Li H (2024) Bioinformatics method predicts hantavirus disrupts vascular permeability to invade cells violently by fibrocystin hydrolase and PTEN\/gtpase-like system. Curr Proteomics 21:730\u2013750. https:\/\/doi.org\/10.2174\/0115701646320190241231083203","journal-title":"Curr Proteomics"},{"key":"5929_CR8","doi-asserted-by":"publisher","first-page":"1731605","DOI":"10.3389\/fbioe.2025.1731605","volume":"13","author":"Y Liu","year":"2025","unstructured":"Liu Y, Wang X, Tao X, Zhang H-K, Liu B, Li Y et al (2025) Notch signaling pathway and heart development, congenital heart disease, and myocardial regeneration. Front Bioeng Biotechnol 13:1731605. https:\/\/doi.org\/10.3389\/fbioe.2025.1731605","journal-title":"Front Bioeng Biotechnol"},{"key":"5929_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s44254-025-00159-6","volume":"3","author":"J Long","year":"2025","unstructured":"Long J, Zhu J, Ma D (2025) Research progress and future perspective in anaesthesiology. Anesthesiol Perioper Sci 3:66. https:\/\/doi.org\/10.1007\/s44254-025-00159-6","journal-title":"Anesthesiol Perioper Sci"},{"key":"5929_CR10","doi-asserted-by":"publisher","first-page":"16149","DOI":"10.1007\/s00210-025-04192-x","volume":"398","author":"J Neumann","year":"2025","unstructured":"Neumann J, Kirchhefer U, Hofmann B, Gergs U (2025) Contractile effects of dexmedetomidine in the human heart. Naunyn Schmiedebergs Arch Pharmacol 398:16149\u201316159. https:\/\/doi.org\/10.1007\/s00210-025-04192-x","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5929_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2026.03.1957","author":"E Pizzo","year":"2026","unstructured":"Pizzo E, Cervantes DO, Piccinini G, Nyantakyi B, Ochoa MT, Sun MY et al (2026) Notch1 deletion reduces arrhythmogenic remodeling after myocardial infarction. Heart Rhythm. https:\/\/doi.org\/10.1016\/j.hrthm.2026.03.1957","journal-title":"Heart Rhythm"},{"key":"5929_CR12","doi-asserted-by":"publisher","first-page":"14067","DOI":"10.1007\/s00210-026-05281-1","volume":"399","author":"S Qu","year":"2026","unstructured":"Qu S, Nie Q, Li J, Zhang B, Chen Z, Zhou L (2026) Integrated multi-omics and experimental validation for identifying novel biomarkers of acute myocardial infarction. Naunyn Schmiedebergs Arch Pharmacol 399:14067\u201314089. https:\/\/doi.org\/10.1007\/s00210-026-05281-1","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5929_CR13","doi-asserted-by":"publisher","first-page":"2409499","DOI":"10.1002\/advs.202409499","volume":"11","author":"H She","year":"2024","unstructured":"She H, Hu Y, Zhao G, Du Y, Wu Y, Chen W et al (2024) Dexmedetomidine ameliorates myocardial ischemia\u2010reperfusion injury by inhibiting MDH2 lactylation via regulating metabolic reprogramming. Adv Sci 11:2409499. https:\/\/doi.org\/10.1002\/advs.202409499","journal-title":"Adv Sci"},{"key":"5929_CR14","doi-asserted-by":"publisher","first-page":"100002","DOI":"10.1016\/j.lddd.2025.100002","volume":"22","author":"J Sun","year":"2025","unstructured":"Sun J, Shao X, Yu F, Chen J, Wei D, Liu B et al (2025) Exploring the mechanism of action of tolvaptan in the treatment of cor pulmonale pulmonary hypertension using network pharmacology and animal-based experiments. Lett Drug des Discov 22:100002. https:\/\/doi.org\/10.1016\/j.lddd.2025.100002","journal-title":"Lett Drug des Discov"},{"key":"5929_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s44254-024-00070-6","volume":"2","author":"X Tan","year":"2024","unstructured":"Tan X, Liu R, Dan L, Huang H, Duan C (2024) Effects of anesthetics on mitochondrial quality control: Mechanisms and clinical implications. APS 2:31. https:\/\/doi.org\/10.1007\/s44254-024-00070-6","journal-title":"APS"},{"key":"5929_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s44254-025-00106-5","volume":"3","author":"NHK Trieu","year":"2025","unstructured":"Trieu NHK, Pham HM, Huynh DQ, Tran LT, Nguyen NT, Mai AT et al (2025) Peripheral VA-ECMO: from evolving indications to perioperative implications. Anesthesiol Perioper Sci 3:26. https:\/\/doi.org\/10.1007\/s44254-025-00106-5","journal-title":"Anesthesiol Perioper Sci"},{"key":"5929_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-023-01688-x","volume":"9","author":"L Xia","year":"2024","unstructured":"Xia L, Chen Y, Wang H, Liu J, Zhang M (2024) Ischemia-reperfusion injury: Molecular mechanisms and therapeutic targets. Signal Transduct Target Ther 9:38. https:\/\/doi.org\/10.1038\/s41392-023-01688-x","journal-title":"Signal Transduct Target Ther"},{"key":"5929_CR18","doi-asserted-by":"publisher","first-page":"178697","DOI":"10.1016\/j.ejphar.2026.178697","volume":"1019","author":"L Yan","year":"2026","unstructured":"Yan L, Lu X, Wang N, Jia P (2026) LncRNA NR_190073.1 mediates the cardioprotective effect of ulinastatin in sepsis through notch signaling. Eur J Pharmacol 1019:178697. https:\/\/doi.org\/10.1016\/j.ejphar.2026.178697","journal-title":"Eur J Pharmacol"},{"key":"5929_CR19","doi-asserted-by":"publisher","first-page":"104228","DOI":"10.1016\/j.redox.2026.104228","volume":"94","author":"J Yang","year":"2026","unstructured":"Yang J, Zhang J, Huang R, Meng K, Liang J, Lin J et al (2026) Advanced glycation end-products exacerbate myocardial ischemia\/reperfusion injury by promoting mitochondrial oxidative damage and PANoptosis in diabetes mellitus. Redox Biol 94:104228. https:\/\/doi.org\/10.1016\/j.redox.2026.104228","journal-title":"Redox Biol"},{"key":"5929_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41589-020-0492-2","volume":"16","author":"D Yuan","year":"2020","unstructured":"Yuan D, Liu Z, Kaindl J, Maeda S, Zhao J, Sun X et al (2020) Activation of the \u03b12B adrenoceptor by the sedative sympatholytic dexmedetomidine. Nat Chem Biol 16:507\u2013512. https:\/\/doi.org\/10.1038\/s41589-020-0492-2","journal-title":"Nat Chem Biol"},{"key":"5929_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3892\/ijmm.2024.5434","volume":"54","author":"Y Yuan","year":"2024","unstructured":"Yuan Y, Huang H, Hu T, Zou C, Qiao Y, Fang M et al (2024) Curcumin pretreatment attenuates myocardial ischemia\/reperfusion injury by inhibiting ferroptosis, autophagy and apoptosis via HES1. Int J Mol Med 54:110. https:\/\/doi.org\/10.3892\/ijmm.2024.5434","journal-title":"Int J Mol Med"},{"key":"5929_CR22","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1007\/s00210-023-02829-3","volume":"397","author":"L Zhao","year":"2024","unstructured":"Zhao L, Shi H, Zhang F, Xue H, Han Q (2024) Hederagenin protects against myocardial ischemia-reperfusion injury via attenuating ALOX5-mediated ferroptosis. Naunyn Schmiedebergs Arch Pharmacol 397:3411\u20133424. https:\/\/doi.org\/10.1007\/s00210-023-02829-3","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5929_CR23","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3892\/mmr.2019.10371","volume":"20","author":"P Zhu","year":"2019","unstructured":"Zhu P, Yang M, He H, Kuang Z, Liang M, Lin A et al (2019) Curcumin attenuates hypoxia\/reoxygenation-induced cardiomyocyte injury by downregulating notch signaling. Mol Med Rep 20:1541\u20131550. https:\/\/doi.org\/10.3892\/mmr.2019.10371","journal-title":"Mol Med Rep"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05929-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05929-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05929-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:22:58Z","timestamp":1790320978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05929-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":23,"alternative-id":["5929"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05929-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"11 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study used a commercially obtained H9c2 cell line and did not involve human participants, human biological material, live animals, animal data, or animal biological material. Formal animal ethics approval was therefore not required for the experiments reported in this manuscript.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors approved the final manuscript and consented to its publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}